Tramadol Versus Placebo and Morphine in the Management of Post-Operative Pain Abdominoplasty
← catalyst calendarSponsored by Avenue Therapeutics, Inc. (industry) · ATXI — their whole pipeline →.
Phase
Phase 3
Status
Active, not recruiting
Study type
Interventional
Design
Randomized · Triple · Treatment
Enrollment
360estimated
Sites
3
Country
United States
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2018-12-14 | actual | When the study began enrolling |
| Primary completion | 2019-05-30 | estimated | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2019-06-30 | estimated | The whole study's end, after follow-up |
| First posted | 2018-12-13 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2019-05-09 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Pain Management
Interventions
- Drug: Tramadol
- Drug: Morphine
- Other: Placebo
Primary outcome
what the primary-completion date above is the date OFThe Sum of Pain Intensity Differences through 24 hours
measured 24 hours post dose
Permalink · ATXI's whole pipeline · Catalyst calendar · Every registered study · What changed